Snoop, spray 45 mcg/dose 15 ml

Xylometazoline belongs to the group of local vasoconstrictors (decongestants) with alpha-adrenomimetic activity, causes narrowing of blood vessels of nasal mucosa, eliminating edema and hyperemia of nasal mucosa, restores nasal passageway, facilitates nasal breathing.

The action of the drug starts 5-10 minutes after application and lasts up to 12 hours.

Indications

Active ingredient

Composition

1 ml of nasal spray contains:

The active ingredient:

Xylometazoline hydrochloride 0.5 mg or 1.0 mg

Associates:

Sea water – 250.0 mg,

Potassium dihydrophosphate – 0.45 mg,

Purified water – 754.35 mg or 753.85 mg.

Theoretical total mass is 1005.3 mg.

How to take, the dosage

Intranasally.

Snoop® nasal spray 0.05%

In children aged 2 to 6 years, 1 injection in each nostril (can be repeated if necessary), up to three times a day.

Adults and children from 6 years of age 2 injections in each nostril, up to three times a day.

The drug should not be used more than 3 times a day and the course of treatment should not last more than 7 days.

The nasal passages should be cleared before use.

Pick off the protective cap. Before first use, squeeze the rim of the spray nozzle several times until an even cloud of “mist” appears. The bottle is ready to use again.

In application, insert the nozzle into the nasal cavity and press once on the rim. The bottle should be held vertically.

Do not spray horizontally or downward. Immediately after injection, it is recommended to breathe in gently through the nose. After use, cover the vial with the protective cap.

Each vial must be used individually.

After therapy, the drug can only be reapplied after a few days.

The duration of use in children should be consulted with the physician.

In case of chronic rhinitis, Snup® 0.05% and 0.1% should only be used under medical supervision, because of the risk of nasal atrophy.

If there is no improvement after treatment, or if symptoms worsen, or new symptoms develop, a physician should be consulted.

To use the drug only according to the directions, route of administration, and dosage listed in the leaflet.

Interaction

Special Instructions

The seawater contained in the product helps maintain the normal physiological condition of the nasal mucosa due to its ability to improve the function of the atomizing epithelium and normalize mucus production in the mucous membrane bocalytic cells.

Do not use continuously for more than 7 days.

The recommended doses should not be exceeded, especially in children and the elderly.

Long-term (more than 7 days) use or overdose of xylomethasoline may decrease the therapeutic effect of the drug and also increases the risk of reactive hyperemia and nasal mucosal atrophy.

Impact on the ability to drive vehicles and operate machinery: While observing the dosage regimen, xylometazoline does not affect concentration and speed of psychomotor reactions.

Synopsis

Features

Contraindications

With caution: lactation, coronary heart disease (angina pectoris), prostatic hyperplasia, diabetes.

Side effects

Overdose

Symptoms:

In an overdose of the drug, the clinical picture is an alternation of phases of central nervous system arousal (restlessness, agitation, hallucinations, seizures) with phases of central nervous system depression (decreased body temperature, lethargy, drowsiness, coma).

The following symptoms may also occur:

Myosis, mydriasis, increased sweating, increased body temperature, pallor, cyanosis, nausea and vomiting, tachycardia, bradycardia, cardiac arrhythmias, cardiac arrest, palpitations, increased arterial

Pressure, decreased blood pressure up to and including shock, pulmonary edema, respiratory depression and apnea, psychogenic disorders.

In children in overdose, there are dominant central effects with seizures, coma and bradycardia, apnea, and increased blood pressure followed by hypotension.

Treatment:

Symptomatic, under medical supervision.

In case of accidental ingestion of the drug – administration of activated charcoal, gastric lavage.

In severe overdose, intensive hospital therapy is indicated.

In serious cases non-selective alpha-adrenoblockers may be used to reduce blood pressure, antipyretic drugs, intubation and artificial ventilation.

Pregnancy use

Contraindicated in pregnancy, with caution breast-feeding.

Similarities